Achieve Life Sciences, Inc.

NASDAQ:ACHV

Biotechnology

Healthcare
$6.78 -7.00%

-$0.38 today

Market cap
$697.68M
Beta
2.26
P/E (TTM)
-5.1
EPS (TTM)
-$0.97
52W Low $2.00High $6.16

Volume 1.09M

Average 1.44M

ACHV Financing Cash Flow

Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.

Achieve Life Sciences, Inc.NASDAQ: ACHV

Financing Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Financing cash flow outflow grows to $21K

Q1 FY2026 financing cash flow was $21K, compared with $0 a year earlier. Trailing-twelve-month financing cash flow was $51.55M. Over 3 fiscal years it compounded at +38.7% a year.

Context

  • Financing cash flow increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly financing cash flow holds near $21K or moves back toward the trailing-twelve-month quarterly average of $12.89M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$21K-99.7% QoQ
Last fiscal yearDec 2025
$51.53M+6.2% YoY
LTMMar 2026
$51.55M+779.8% YoY
Financing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year+6.2%——
3-year CAGR+38.7%——
5-year CAGR——
10-year CAGR——

Financing Cash Flow history

USD · from the cash flow

Latest · FY2025
51.53M USD
Year-over-year change
+6.2%
4-year CAGR
+8.9%

Financing Cash Flow vs competitors

How ACHV compares with its peers on the latest reported figures

No competitor Financing Cash Flow figures are available to compare.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(33.15M)(42.35M)(29.82M)(39.83M)(54.65M)
Depreciation & Amortization250K236K228K229K228K
Deferred Income Tax00000
Stock-Based Compensation2.19M3.27M3.44M5.33M8.76M
Change in Working Capital1.23M79K(778K)2.41M(4.27M)
Accounts Receivables(153K)48K0111K0
Inventory00000
Accounts Payables509K799K(1.04M)1.33M(1.08M)
Other Working Capital878K(768K)264K969K(3.18M)
Other Non-Cash Items41K1.2M2.45M2.09M460K
Operating Cash Flow(29.44M)(37.57M)(24.48M)(29.77M)(49.47M)
Capital Expenditures00(21K)0(3K)
Acquisitions (Net)00000
Purchases of Investments000(47.89M)(24.76M)
Sales of Investments00026.31M30.87M
Other Investing Activities00003K
Investing Cash Flow00(21K)(21.58M)6.11M
Debt Repayment14.93M00(8.3M)5M
Common Stock Issued21.34M19.21M15.3M56.08M46.53M
Common Stock Repurchased00(30K)00
Dividends Paid00000
Other Financing Activities338K103K7K746K0
Financing Cash Flow36.61M19.32M15.28M48.53M51.53M
Effect of Forex Changes(1K)3K(3K)30K3K
Net Change in Cash7.17M(18.25M)(9.23M)(2.79M)8.18M
Free Cash Flow(29.44M)(37.57M)(24.5M)(29.77M)(49.47M)

Achieve Life Sciences, Inc.

NASDAQ:ACHV

Intrinsic Alpha fair value

Locked

Current Price

$6.78

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.